PubRank

Kensuke Kojima

Author PubWeight™ 28.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology 2013 2.13
2 Autoimmune neutropenia associated with multiple sclerosis. Intern Med 2003 1.46
3 Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. Gastroenterology 2013 1.26
4 Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells. J Immunol 2003 1.05
5 An on-chip cardiomyocyte cell network assay for stable drug screening regarding community effect of cell network size. Analyst 2007 1.03
6 Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma. Cancer Sci 2014 1.02
7 Gene signatures in the management of hepatocellular carcinoma. Semin Oncol 2012 1.02
8 MDM2 antagonist Nutlin-3 enhances bortezomib-mediated mitochondrial apoptosis in TP53-mutated mantle cell lymphoma. Cancer Lett 2010 0.98
9 Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells. Ann Hematol 2012 0.94
10 Mitochondrial uncoupling and the reprograming of intermediary metabolism in leukemia cells. Front Oncol 2013 0.89
11 Expression of SOCS3 mRNA in bone marrow cells from CML patients associated with cytogenetic response to IFN-alpha. Leuk Res 2005 0.86
12 Dependence of the community effect of cultured cardiomyocytes on the cell network pattern. Biochem Biophys Res Commun 2007 0.85
13 Hyponatremia during administration of tacrolimus in an allogeneic bone marrow transplant recipient. Int J Hematol 2003 0.84
14 Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin. Leuk Res 2004 0.83
15 Can t(8;21) oligoblastic leukemia be called a myelodysplastic syndrome? Eur J Haematol 2002 0.82
16 Ever-advancing chronic myeloid leukemia treatment. Int J Clin Oncol 2013 0.81
17 Follicular dendritic cell tumor as an unknown primary tumor. Int J Clin Oncol 2007 0.81
18 Association of increased type I collagen expression and relative stromal overgrowth in mouse epididymis neonatally exposed to diethylstilbestrol. Mol Reprod Dev 2005 0.81
19 Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilization. Transfusion 2002 0.81
20 Gene expression profiling of cathepsin D, metallothioneins-1 and -2, osteopontin, and tenascin-C in a mouse spinal cord injury model by cDNA microarray analysis. Acta Neuropathol 2004 0.79
21 Acute promyelocytic leukemia with tetraploid karyotype: first report in the Western hemisphere and update of previous reports. Leuk Res 2011 0.79
22 ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia. Int J Hematol 2014 0.78
23 [A case of bronchiolitis obliterans after allogeneic bone marrow transplantation for acute lymphocytic leukemia]. Nihon Kokyuki Gakkai Zasshi 2002 0.78
24 NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes. Br J Haematol 2009 0.78
25 [Role of p53 in leukemia]. Rinsho Ketsueki 2014 0.77
26 Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors. Transfusion 2004 0.77
27 Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia. Int J Hematol 2015 0.76
28 Glanzmann thrombasthenia with acute myeloid leukemia successfully treated by bone marrow transplantation. Int J Hematol 2005 0.76
29 Megakaryoblastic leukemia cell line MOLM-16 derived from minimally differentiated acute leukemia with myeloid/NK precursor phenotype. Leuk Res 2003 0.76
30 Acute myeloid leukemia cell lines MOLM-17 and MOLM-18 derived from patient with advanced myelodysplastic syndromes. Leuk Res 2005 0.75
31 [A Surgical Case of Solitary Fibrous Tumor Originating from the Greater Omentum]. Gan To Kagaku Ryoho 2016 0.75
32 Diffuse bone marrow uptake of fluorodeoxyglucose in a patient with aleukaemic acute lymphoblastic leukaemia. Br J Haematol 2014 0.75
33 Rituximab-containing Chemotherapy (R-CHOP)-induced Kaposi's Sarcoma in an HIV-negative Patient with Diffuse Large B Cell Lymphoma. Intern Med 2015 0.75
34 Novel B-cell acute lymphoblastic leukemia sister cell lines BALM 19-23 and BALM-26 with interclonal proliferative and phenotypic heterogeneity from a patient with hypercalcemia. Hum Cell 2002 0.75
35 Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases. Int J Hematol 2002 0.75
36 Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia. Intern Med 2016 0.75
37 Small lymphocytic lymphoma presenting as bulky renal incidentaloma. Int J Hematol 2014 0.75
38 Successful treatment with cyclosporin A of myelodysplastic syndrome with erythroid hypoplasia associated with t(6;8)(q15;q22). Cancer Genet Cytogenet 2003 0.75
39 [Clinical evaluation of cefozopran as treatment for febrile neutropenia]. Gan To Kagaku Ryoho 2004 0.75
40 Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma. Intern Med 2016 0.75
41 Coexistence of ALK-anaplastic large cell lymphoma and CD4+ T cell large granular lymphocytic leukemia. Ann Hematol 2014 0.75
42 Multilineage involvement in hypereosinophilic syndrome terminating in granulocytic sarcoma and leukaemic transformation with trisomy 8. Br J Haematol 2002 0.75
43 Thymic epithelial hyperplasia with nodular sclerosis Hodgkin's disease. Leuk Lymphoma 2002 0.75
44 [Abnormal p53-HDM2 interaction in hematological malignancy]. Nihon Rinsho 2014 0.75
45 [Molecular targeted therapy in lymphoid leukemias]. Nihon Rinsho 2014 0.75